
About ESLHO
The European Scientific foundation for Laboratory Hemato Oncology (ESLHO) is a scientifically independent foundation that promotes innovation, standardization, quality control and education of laboratory diagnostics focused on lymphoid malignancies, together with the associated consortia EuroClonality, EuroFlow and EuroMRD.
Every year in November, ESLHO organizes a scientific symposium. During this event, speakers from all over the world share their knowledge and talk about the latest results from research projects related to laboratory diagnostics for lymphoid malignancies.
The IVDR, which will regulate all in vitro diagnostic medical devices (IVDs) from May 2022 onwards, will have a major impact on IVD manufacturers as well as diagnostic laboratories. To aid laboratories from the ESLHO networks with their preparations for the IVDR, including compliance to the IVDR requirements for in-house devices, ESLHO provides information and support in the form of lectures, symposia, publications and a dedicated web page.
Research & Innovation
Standardization
Quality Assessment
Education
News

The registration for the “2025 External Quality Assessment Scheme for IG/TR Clonality Testing in Suspected Lymphoproliferations/Lymphoma” is now open. This EQA scheme is organized by the EuroClonality Consortium in collaboration with the Biomedical Quality Assurance Research Unit of the University of Leuven led by Prof. Dr. Els Dequeker.
This year, participants in the IG scheme will receive 3 DNA samples and 2 paper-based cases. For the TR scheme, labs will receive 2 DNA samples and 3 paper-based cases.
Just like last year, participants have the option to submit results from GeneScan/heteroduplex or NGS methods for the DNA samples. Analysis of the paper cases based on GeneScan patterns will still be mandatory and will be scored as usual.
Participation fee
The fee for participation in either the IG scheme or TR scheme is € 460. This fee covers the preparation and sending of samples, an evaluation report, as well as the administrative organization of the schemes.
Detailed information on the organization of the EQA scheme, registration and evaluation of results can be found on the EQA website: www.eqascheme.org.
EHA-SWG
ESLHO is a Specialized Working Group of the European Hematology Association. At the annual EHA Congress, ESLHO presents its innovations in the special EHA-SWG sessions.
Read more about ESLHO’s EHA-SWG activities
